Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N -Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression

Witkin, J M ; Mitchell, S N ; Wafford, K A ; Carter, G ; Gilmour, G ; Li, J ; Eastwood, B J ; Overshiner, C ; Li, X ; Rorick-Kehn, L ; Rasmussen, K ; Anderson, W H ; Nikolayev, A ; Tolstikov, V V ; Kuo, M-S ; Catlow, J T ; Li, R ; Smith, S C ; Mitch, C H ; Ornstein, P L ; Swanson, S ; Monn, J A

The Journal of pharmacology and experimental therapeutics, 2017-04, Vol.361 (1), p.68-86 [Periódico revisado por pares]

United States

Texto completo disponível